vs
CuriosityStream Inc.（CURI）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是CuriosityStream Inc.的1.9倍（$35.5M vs $19.2M），CuriosityStream Inc.净利率更高（-19.7% vs -304.2%，领先284.5%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 35.8%），CuriosityStream Inc.自由现金流更多（$3.9M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 26.5%）
CuriosityStream是来自美国的流媒体订阅点播服务商，主打纪实类影视内容，涵盖纪录片长片、系列纪实节目与电视栏目。除了品牌同名的视频点播订阅服务外，该公司还开设了Curiosity纪实线性电视频道，目前已接入FuboTV、Roku频道等多个平台。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
CURI vs RXRX — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $19.2M | $35.5M |
| 净利润 | $-3.8M | $-108.1M |
| 毛利率 | — | 59.8% |
| 营业利润率 | -17.6% | -304.8% |
| 净利率 | -19.7% | -304.2% |
| 营收同比 | 35.8% | 681.7% |
| 净利润同比 | -34.6% | 39.6% |
| 每股收益（稀释后） | $-0.07 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $19.2M | $35.5M | ||
| Q3 25 | $18.4M | $5.2M | ||
| Q2 25 | $19.0M | $19.2M | ||
| Q1 25 | $15.1M | $14.7M | ||
| Q4 24 | $14.1M | $4.5M | ||
| Q3 24 | $12.6M | $26.1M | ||
| Q2 24 | $12.4M | $14.4M | ||
| Q1 24 | $12.0M | $13.8M |
| Q4 25 | $-3.8M | $-108.1M | ||
| Q3 25 | $-3.7M | $-162.3M | ||
| Q2 25 | $784.0K | $-171.9M | ||
| Q1 25 | $319.0K | $-202.5M | ||
| Q4 24 | $-2.8M | $-178.9M | ||
| Q3 24 | $-3.1M | $-95.8M | ||
| Q2 24 | $-2.0M | $-97.5M | ||
| Q1 24 | $-5.0M | $-91.4M |
| Q4 25 | — | 59.8% | ||
| Q3 25 | — | -183.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | — | -181.4% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | — | 36.2% | ||
| Q1 24 | — | 19.1% |
| Q4 25 | -17.6% | -304.8% | ||
| Q3 25 | -24.5% | -3327.6% | ||
| Q2 25 | 2.5% | -916.8% | ||
| Q1 25 | 0.5% | -1297.9% | ||
| Q4 24 | -27.4% | -4042.4% | ||
| Q3 24 | -25.8% | -377.1% | ||
| Q2 24 | -20.6% | -697.4% | ||
| Q1 24 | -30.4% | -698.4% |
| Q4 25 | -19.7% | -304.2% | ||
| Q3 25 | -20.4% | -3135.3% | ||
| Q2 25 | 4.1% | -894.2% | ||
| Q1 25 | 2.1% | -1373.3% | ||
| Q4 24 | -19.9% | -3935.5% | ||
| Q3 24 | -24.3% | -367.5% | ||
| Q2 24 | -16.4% | -676.6% | ||
| Q1 24 | -42.0% | -662.4% |
| Q4 25 | $-0.07 | $-0.17 | ||
| Q3 25 | $-0.06 | $-0.36 | ||
| Q2 25 | $0.01 | $-0.41 | ||
| Q1 25 | $0.01 | $-0.50 | ||
| Q4 24 | $-0.05 | $-0.56 | ||
| Q3 24 | $-0.06 | $-0.34 | ||
| Q2 24 | $-0.04 | $-0.40 | ||
| Q1 24 | $-0.09 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $27.3M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $41.5M | $1.1B |
| 总资产 | $75.7M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
| Q4 25 | $27.3M | $743.3M | ||
| Q3 25 | $27.8M | $659.8M | ||
| Q2 25 | $28.1M | $525.1M | ||
| Q1 25 | $33.4M | $500.5M | ||
| Q4 24 | $32.1M | $594.4M | ||
| Q3 24 | $33.2M | $427.6M | ||
| Q2 24 | $39.5M | $474.3M | ||
| Q1 24 | $38.8M | $296.3M |
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
| Q4 25 | $41.5M | $1.1B | ||
| Q3 25 | $47.2M | $1.0B | ||
| Q2 25 | $49.8M | $919.1M | ||
| Q1 25 | $58.1M | $933.9M | ||
| Q4 24 | $57.8M | $1.0B | ||
| Q3 24 | $62.2M | $524.6M | ||
| Q2 24 | $64.8M | $584.4M | ||
| Q1 24 | $67.0M | $401.2M |
| Q4 25 | $75.7M | $1.5B | ||
| Q3 25 | $74.7M | $1.4B | ||
| Q2 25 | $78.7M | $1.3B | ||
| Q1 25 | $85.3M | $1.3B | ||
| Q4 24 | $86.2M | $1.4B | ||
| Q3 24 | $87.6M | $726.5M | ||
| Q2 24 | $90.9M | $775.9M | ||
| Q1 24 | $94.6M | $557.8M |
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $4.0M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $3.9M | $-47.3M |
| 自由现金流率自由现金流/营收 | 20.5% | -133.1% |
| 资本支出强度资本支出/营收 | 0.1% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-378.3M |
8季度趋势，按日历期对齐
| Q4 25 | $4.0M | $-46.1M | ||
| Q3 25 | $4.4M | $-117.4M | ||
| Q2 25 | $2.8M | $-76.4M | ||
| Q1 25 | $1.9M | $-132.0M | ||
| Q4 24 | $3.0M | $-115.4M | ||
| Q3 24 | $2.3M | $-59.2M | ||
| Q2 24 | $2.2M | $-82.2M | ||
| Q1 24 | $666.0K | $-102.3M |
| Q4 25 | $3.9M | $-47.3M | ||
| Q3 25 | — | $-117.6M | ||
| Q2 25 | — | $-79.6M | ||
| Q1 25 | $1.8M | $-133.8M | ||
| Q4 24 | — | $-116.7M | ||
| Q3 24 | — | $-63.8M | ||
| Q2 24 | — | $-83.4M | ||
| Q1 24 | — | $-109.0M |
| Q4 25 | 20.5% | -133.1% | ||
| Q3 25 | — | -2272.5% | ||
| Q2 25 | — | -413.9% | ||
| Q1 25 | 12.2% | -907.4% | ||
| Q4 24 | — | -2567.7% | ||
| Q3 24 | — | -244.6% | ||
| Q2 24 | — | -578.5% | ||
| Q1 24 | — | -789.9% |
| Q4 25 | 0.1% | 3.5% | ||
| Q3 25 | 0.0% | 4.7% | ||
| Q2 25 | 0.0% | 16.4% | ||
| Q1 25 | 0.5% | 12.4% | ||
| Q4 24 | 0.0% | 28.6% | ||
| Q3 24 | 0.0% | 17.5% | ||
| Q2 24 | 0.0% | 8.2% | ||
| Q1 24 | 0.0% | 48.2% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 3.56× | — | ||
| Q1 25 | 6.03× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
